comparemela.com

Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) reached a new 52-week high during trading on Thursday after The Goldman Sachs Group raised their price target on the stock from $3.20 to $4.80. The Goldman Sachs Group currently has a neutral rating on the stock. Autolus Therapeutics traded as high as $5.00 and […]

Related Keywords

William Blair ,Goldman Sachs Group ,Needham Company ,Deutsche Bank Aktiengesellschaft ,Advisor Group Holdings Inc ,Sei Investments Co ,Renaissance Technologies ,Ci Private Wealth ,Nasdaq ,Autolus Therapeutics Company Profile ,Autolus Therapeutics ,Get Free Report ,Bank Aktiengesellschaft ,Sigma Advisers ,Group Holdings ,Autolus Therapeutics Daily ,Nasdaq Autl ,Autl ,Medical ,Stocks ,Technicals ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.